The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
Open accessAbstract
Alzheimer's Disease (AD) is the major form of senile dementia, characterized by neuronal loss, extracellular deposits, and neurofibrillary tangles. It is accompanied by a loss of cholinergic tone, and acetylcholine (ACh) levels in the brain, which were hypothesized to be responsible for the cognitive decline observed in AD. Current medication is restricted to enhancing cholinergic signalling for symptomatic treatment of AD patients. The nicotinic acetylcholine receptor family (nAChR) and the muscarinic acetylcholine receptor family (mAChR) are the target of ACh in the brain. Both families of receptors are affected in AD. It was demonstrated that amyloid beta (Aβ) interacts with nAChRs. Here we discuss how Aβ activates or inhibits nAChRs, and how this interaction contributes to AD pathology. We will discuss the potential role of nAChRs as therapeutic targets. This article is part of the Special Issue entitled 'The Nicotinic Acetylcholine Receptor: From Molecular Biology to Cognition'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“…hallmarks consisting of an accumulation of Amyloid ß peptide (Aß) in extracellular plaques, intracellular deposits of tau protein, neuronal loss and, more recently, a prominent synaptic loss was identified (Braak and Braak, 1991; Masliah et al., 2001; Selkoe, 1991; Spires-Jones and Hyman, 2014).”
BackgroundThe cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · cited 2×
“…in neurodegenerative diseases, and in particular in the case of AD, led to the formulation of the “cholinergic hypothesis” of geriatric disorders (Bartus et al., 1982; Contestabile, 2011), according to which the reduction in cholinergic innervation is responsible for the cognitive decline…”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · cited 2×
“…in nicotine and ACh binding sites in cerebral cortex of patients suffering from AD, demonstrating a decrease of both nAChR and mAChR populations (Gotti et al., 2006a; Paterson and Nordberg, 2000; Perry et al., 1981, 1985, 1987, 1988; Shimohama et al., 1986; Whitehouse et al., 1981, 1982, 1986).”
BackgroundSELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · cited 1×
“In addition, several authors observed a reduction in the activity of acetylcholinesterase (AChE), the enzyme that metabolises ACh after its release in the synaptic cleft (Auld et al., 2002; Bowen et al., 1976; Coyle et al., 1983; Davies and Maloney, 1976; Perry et al., 1978).”
BackgroundAlzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“In the APP-α 7KO line the lack of α 7 was sufficient to preserve synaptic terminals and dendrites, rescuing levels of synaptophysin and MAP2 to reach that of aged-matched WT controls.”
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 1×
“…a mouse model, that we will refer to as APP-α 7KO, was generated by crossing an AD model that expresses the human APP (Amyloid precursor protein) with the Swedish (KM670/671NL) and the Indiana (V717F) mutations (Mucke et al., 2000), with the α 7 nAChR null-mutant (Orr-Urtreger et al., 1997).”
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123 · cited 1×
“It is known that AD mice display some pathological modifications, like loss of synaptic and dendritic markers, such as synaptophysin and MAP2 (Games et al., 1995; Hsia et al., 1999).”
BackgroundFilamins as integrators of cell mechanics and signalling
Stossel, T. P., Condeelis, J., Cooley, L., Hartwig, J. H., Noegel, A., Schleicher, M., & Shapiro, S. S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052082 · Cited by 1,020
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970 · cited 2×
“αBungarotoxin sensitive and αBungarotoxin insensitive receptors (Gotti and Clementi, 2004).”
BackgroundBrain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 782
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · cited 5×
“An in vivo Aß infusion in mice was able to enhance hippocampal dependent memory, highlighted with memory tasks such as the Morris water maze and contextual fear conditioning, which are both hippocampus dependent behavioural tasks (Puzzo et al., 2008).”
InfluentialAltered expression of synaptic proteins occurs early during progression of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.1.127 · Cited by 720
Bigl, V., Woolf, N. J., & Butcher, L. L. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90101-0 · Cited by 691
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 666
Cognitive functions of cortical acetylcholine: toward a unifying hypothesis
Sarter, M., & Bruno, J. P. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00009-4 · Cited by 663
Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E., & Perry, R. H. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.413 · Cited by 571
Orr-Urtreger, A., Göldner, F. M., Saeki, M., Lorenzo, I., Goldberg, L., De Biasi, M., Dani, J. A., Patrick, J. W., & Beaudet, A. L. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09165.1997 · Cited by 497
Nicotinic acetylcholine binding sites in Alzheimer's disease
Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L., & Kellar, K. J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90819-x · Cited by 486
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04125.2001 · Cited by 462 · cited 3×
“…incubation and lower concentration lead to receptor activation (Dineley et al., 2002; Dougherty et al., 2003; Puzzo et al., 2008), while longer incubation period and higher peptide concentrations give rise to an inhibitory effect (Dineley et al., 2001; Parri et al., 2011; Pettit et al., 2001).”
Desensitization of neuronal nicotinic receptors
Quick, M. W., & Lester, R. A. J. (2002) · Journal of Neurobiology · doi:10.1002/neu.10109 · Cited by 456
Wang, H., Lee, D. H. S., Davis, C. B., & Shank, R. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751155.x · Cited by 435
Allosteric Receptors after 30 Years
Changeux, J.-P., & Edelstein, S. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80616-9 · Cited by 431
Oligomers on the Brain: the Emerging Role of Soluble Protein Aggregates in Neurodegeneration.
Walsh, D., & Selkoe, D. (2004) · Protein & Peptide Letters · doi:10.2174/0929866043407174 · Cited by 428
Le Novere, N., & Changeux, J.-P. (1995) · Journal of Molecular Evolution · doi:10.1007/bf00167110 · Cited by 427
Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., & Akaike, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008035200 · Cited by 415
Simons, M., Schwärzler, F., Lütjohann, D., Von Bergmann, K., Beyreuther, K., Dichgans, J., Wormstall, H., Hartmann, T., & Schulz, J. B. (2002) · Annals of Neurology · doi:10.1002/ana.10292 · Cited by 415
Identification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387
The history of the cholinergic hypothesis
Contestabile, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.044 · Cited by 374
Selkoe, D. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004457 · Cited by 363
Desensitization of nicotinic ACh receptors: shaping cholinergic signaling
GINIATULLIN, R., NISTRI, A., & YAKEL, J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.04.009 · Cited by 357
Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J.-P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 343
β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons
Liu, Q.-S., Kawai, H., & Berg, D. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081553598 · Cited by 331
β-Amyloid1–42Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice
Pettit, D. L., Shao, Z., & Yakel, J. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0003.2001 · Cited by 290
The Nucleus Basalis Magnocellularis Cholinergic System: One Hundred Years of Progress
Wenk, G. L. (1997) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1996.3757 · Cited by 286
Heterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282
The Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons
Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C., & Pearson, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05531.2003 · Cited by 266
Changes in Nicotinic and Muscarinic Cholinergic Receptors in Alzheimer‐Type Dementia
Shimohama, S., Taniguchi, T., Fujiwara, M., & Kameyama, M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb12960.x · Cited by 257
β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes
Dineley, K. T., Bell, K. A., Bui, D., & Sweatt, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200066200 · Cited by 240
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.008 · Cited by 233 · cited 1×
“Knock-out (KO) mice for this subunit did not show a clear cognitive or attention deficit, except when the behavioural paradigm used implied prolonged sessions (Young et al., 2004, 2007).”
MethodYoung, J. W., Finlayson, K., Spratt, C., Marston, H. M., Crawford, N., Kelly, J. S., & Sharkey, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300393 · Cited by 218
Khiroug, S. S., Harkness, P. C., Lamb, P. W., Sudweeks, S. N., Khiroug, L., Millar, N. S., & Yakel, J. L. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013847 · Cited by 216
β-Amyloid Regulation of Presynaptic Nicotinic Receptors in Rat Hippocampus and Neocortex
Dougherty, J. J., Wu, J., & Nichols, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06740.2003 · Cited by 214
Studies on human memory: The interactions of diazepam, scopolamine, and physostigmine
Ghoneim, M. M., & Mewaldt, S. P. (1977) · Psychopharmacology · doi:10.1007/bf00426592 · Cited by 213
Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes
Perry, E. K., Blessed, G., Tomlinson, B. E., Perry, R. H., Crow, T. J., Cross, A. J., Dockray, G. J., Dimaline, R., & Arregui, A. (1981) · Neurobiology of Aging · doi:10.1016/0197-4580(81)90032-4 · Cited by 212
Oddo, S., Caccamo, A., Green, K. N., Liang, K., Tran, L., Chen, Y., Leslie, F. M., & LaFerla, F. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408500102 · Cited by 211 · cited 4×
“This kinase is sensitive to Ca, whose levels are increased following nAChR activation (Oddo et al., 2005).”
BackgroundResultInfluentialNordberg, A., Hellström‐Lindahl, E., Lee, M., Johnson, M., Mousavi, M., Hall, R., Perry, E., Bednar, I., & Court, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00874.x · Cited by 209
Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors
Zoli, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1235 · Cited by 208
Hernandez, C. M., Kayed, R., Zheng, H., Sweatt, J. D., & Dineley, K. T. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5038-09.2010 · Cited by 204 · cited 4×
“Two examples from the literature showed strikingly opposite outcomes (Dziewczapolski et al., 2009; Hernandez et al., 2010).”
BackgroundMethodResultInfluentialMuir, J. L., Page, K. J., Sirinathsinghji, D. J. S., Robbins, T. W., & Everitt, B. J. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90128-d · Cited by 199 · cited 1×
“The cholinergic system is also involved in attention processes (Muir et al., 1993; Sarter and Bruno, 1997; Wenk, 1997).”
BackgroundDziewczapolski, G., Glogowski, C. M., Masliah, E., & Heinemann, S. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6159-08.2009 · Cited by 198
Sudweeks, S. N., & Yakel, J. L. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00515.x · Cited by 197
Nicotinic α7 receptors: Synaptic options and downstream signaling in neurons
Berg, D. K., & Conroy, W. G. (2002) · Journal of Neurobiology · doi:10.1002/neu.10116 · Cited by 197
Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention
Guillem, K., Bloem, B., Poorthuis, R. B., Loos, M., Smit, A. B., Maskos, U., Spijker, S., & Mansvelder, H. D. (2011) · Science · doi:10.1126/science.1207079 · Cited by 191
Self-citationResearch update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease
Parri, H. R., Hernandez, C. M., & Dineley, K. T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.039 · Cited by 187
Liu, Q., Huang, Y., Xue, F., Simard, A., DeChon, J., Li, G., Zhang, J., Lucero, L., Wang, M., Sierks, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3952-08.2009 · Cited by 182
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.
Perry, E. K., Perry, R. H., Smith, C. J., Dick, D. J., Candy, J. M., Edwardson, J. A., Fairbairn, A., & Blessed, G. (1987) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.6.806 · Cited by 173
Biton, B., Bergis, O. E., Galli, F., Nedelec, A., Lochead, A. W., Jegham, S., Godet, D., Lanneau, C., Santamaria, R., Chesney, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301189 · Cited by 173
Scopolamine induced learning failures in man
Petersen, R. C. (1977) · Psychopharmacology · doi:10.1007/bf00426713 · Cited by 172
Glutamatergic Synapse Formation is Promoted by α7-Containing Nicotinic Acetylcholine Receptors
Lozada, A. F., Wang, X., Gounko, N. V., Massey, K. A., Duan, J., Liu, Z., & Berg, D. K. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6246-11.2012 · Cited by 152
Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice
Hellström‐Lindahl, E., COURT, J. A., Keverne, J., Svedberg, M. M., Lee, M., Marutle, A., Thomas, A. J., Perry, E. K., Bednar, I., & Nordberg, A. K. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03377.x · Cited by 135
Gotti, C., Moretti, M., Bohr, I., Ziabreva, I., Vailati, S., Longhi, R., Riganti, L., Gaimarri, A., McKeith, I. G., Perry, R. H., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.005 · Cited by 126
Wu, J., Kuo, Y., George, A. A., Xu, L., Hu, J., & Lukas, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400335200 · Cited by 123
A structural basis for memory storage in mammals
Woolf, N. J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00094-4 · Cited by 121
Deficits in attentional control: Cholinergic mechanisms and circuitry-based treatment approaches.
Sarter, M. F., & Paolone, G. (2011) · Behavioral Neuroscience · doi:10.1037/a0026227 · Cited by 119
Nicotinic Receptors Modulate Transmitter Cross Talk in the CNS: Nicotinic Modulation of Transmitters
Wonnacott, S., Barik, J., Dickinson, J., & Jones, I. W. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:137 · Cited by 111
Wang, H.-Y., Stucky, A., Liu, J., Shen, C., Trocmé, C., & Morain, P. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6088-08.2009 · Cited by 107
Statin therapy in Alzheimer's disease
Sparks, D. L., Sabbagh, M., Connor, D. J., Soares, H. D., Lopez, J., Stankovic, G. R., Johnson‐Traver, S., Ziolkowski, C. H. J., & Browne, P. J. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00689.x · Cited by 105
Activation of α 7 nicotinic acetylcholine receptor promotes survival of spinal cord motoneurons
Messi, M. L., Renganathan, M., Grigorenko, E. V., & Delbono, O. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00600-5 · Cited by 100
Moretti, M., Zoli, M., George, A. A., Lukas, R. J., Pistillo, F., Maskos, U., Whiteaker, P., & Gotti, C. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093377 · Cited by 96
Self-citationInestrosa, N. C., Godoy, J. A., Vargas, J., Arrázola, M. S., Ríos, J. A., Carvajal, F. J., Serrano, F. G., & Farías, G. G. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8242-1 · Cited by 93
Cotinine Reduces Amyloid-β Aggregation and Improves Memory in Alzheimer's Disease Mice
Echeverría, V., Zeitlin, R., Burgess, S., Patel, S. P., Barman, A., Thakur, G., Mamcarz, M., Wang, L., Sattelle, D. B., Kirschner, D. A., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102136 · Cited by 90
Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease
Echeverría, V., & Zeitlin, R. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00317.x · Cited by 86
Safety of Cotinine in Humans: Physiologic, Subjective, and Cognitive Effects
Hatsukami, D. K., Grillo, M. A., Pentel, P. R., Oncken, C. A., & Bliss, R. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)80001-9 · Cited by 84
Liu, Q., Huang, Y., Shen, J., Steffensen, S. C., & Wu, J. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-155 · Cited by 83
Lamb, P. W., Melton, M. A., & Yakel, J. L. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:013 · Cited by 78
AMYLOID PRECURSOR PROTEIN IN SENILE PLAQUES OF ALZHEIMER DISEASE
Perry, G. L., Lipphardt, S., Kancherla, M., Gambetti, P. L., Maggiora, L. L., Lobl, T. J., Mulvihill, P., Mijares, M., Sharma, S. K., Cornette, J. C., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90219-x · Cited by 74
Yang, R., Chen, L., Wang, H., Xu, B., Tomimoto, H., & Chen, L. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.035 · Cited by 73
Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A
Wang, H.-Y., Bakshi, K. P., Frankfurt, M., Stucky, A., Goberdhan, M., Shah, S. M., & Burns, L. H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0354-12.2012 · Cited by 72
Pregnenolone sulfate as a modulator of synaptic plasticity
Smith, C. C., Gibbs, T. T., & Farb, D. H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3643-x · Cited by 71
Murray, T. A., Bertrand, D., Papke, R. L., George, A. A., Pantoja, R., Srinivasan, R., Liu, Q., Wu, J., Whiteaker, P., Lester, H. A., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074088 · Cited by 70
Cholinergic receptors: dual roles in transduction and plasticity
Morley, B. J., & Happe, H. K. (2000) · Hearing Research · doi:10.1016/s0378-5955(00)00124-6 · Cited by 69
Lilja, A. M., Porras, O., Storelli, E., Nordberg, A., & Marutle, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101242 · Cited by 57 · cited 1×
“The oligomeric form of Aß 1-40 was able to activate α 7 nAChR expressed in SH-SY5Y cell line (Lilja et al., 2011).”
Tozaki‐Saitoh, H., Matsumoto, A., Kanno, T., Nagai, K., Nagata, T., Yamamoto, S., & Nishizaki, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00429-1 · Cited by 57
Wang, H.-Y., Bakshi, K. P., Shen, C., Frankfurt, M., Trocmé, C., & Morain, P. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.031 · Cited by 55
Kim, H.-J., Moon, W., & Han, S. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122320 · Cited by 52
Gao, J., Adam, B.-L., & Terry, A. V. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.02.008 · Cited by 51
Pym, L. J., Kemp, M., Raymond, V., Buckingham, S. D., Boyd, C. A. R., & Sattelle, D. B. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706403 · Cited by 50
Pandya, A. A., & Yakel, J. L. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9509-3 · Cited by 50
Martin, S. E., de Fiebre, N. E. C., & de Fiebre, C. M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.016 · Cited by 39
Ren, K., King, M. A., Liu, J., Siemann, J. K., Altman, M., Meyers, C., Hughes, J. A., & Meyer, E. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.013 · Cited by 36
Arora, K., Alfulaij, N., Higa, J. K., Panee, J., & Nichols, R. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.453746 · Cited by 33
Søderman, A., Mikkelsen, J. D., West, M. J., Christensen, D. Z., & Jensen, M. S. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.049 · Cited by 32
Shim, S. B., Lee, S. H., Chae, K. R., Kim, C. K., Hwang, D. Y., Kim, B. G., Jee, S. W., Lee, S. H., Sin, J. S., Bae, C. J., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9629-5 · Cited by 32
Simvastatin Exerts Antiamnesic Effect in Aβ25‐35‐Injected Mice
Zhi, W., Zeng, Y., Lu, Z., Qu, W., Chen, W., Chen, L., & Chen, L. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12190 · Cited by 31
Søderman, A., Thomsen, M. S., Hansen, H. H., Nielsen, E. Ø., Jensen, M. S., West, M. J., & Mikkelsen, J. D. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.062 · Cited by 28
Effects of soluble β-amyloid on the release of neurotransmitters from rat brain synaptosomes
Olivero, G., Grilli, M., Chen, J., Preda, S., Mura, E., Govoni, S. M., & Marchi, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00166 · Cited by 25
Zanardi, A., Ferrari, R., Leo, G., Maskos, U., Changeux, J., & Zoli, M. (2007) · The FASEB Journal · doi:10.1096/fj.07-8260com · Cited by 20
Self-citation
Cited by
Molecular Targets of Cannabidiol in Neurological Disorders
Ibeas Bih, C., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 578
Drug candidates in clinical trials for Alzheimer’s disease
Hung, S.-Y., & Fu, W.-M. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0355-7 · Cited by 420
“The nicotinic acetylcholine receptor family (nAChR) and the muscarinic acetylcholine receptor family (mAChR) are targeted by acetylcholine in the brain [18].”
BackgroundConducting polymer-based electrochemical biosensors for neurotransmitters: A review
Moon, J.-M., Thapliyal, N., Hussain, K. K., Goyal, R. N., & Shim, Y.-B. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.11.069 · Cited by 390
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Hussain, G., Rasul, A., Anwar, H., Aziz, N., Razzaq, A., Wei, W., Ali, M., Li, J., & Li, X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23247 · Cited by 351
Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
Bachurin, S. O., Bovina, E. V., & Ustyugov, A. A. (2017) · Medicinal Research Reviews · doi:10.1002/med.21434 · Cited by 304
Metadata
- Authors
- Lombardo, S., & Maskos, U.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 96
- Issue
- Pt B
- Pages
- 255-262
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2088034288
- Cited by
- 299
- References
- 111
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.